Herbalife Reaffirms 2026 Guidance Amid Steady Growth Outlook
Event summary
- Herbalife reaffirmed its Q3 and full-year 2026 guidance on August 31, 2026, maintaining projections from August 5, 2026.
- Net sales growth expected at +0.5% to +4.5% YoY for Q3 and +2.5% to +5.5% YoY for full-year 2026 on a reported basis.
- Adjusted EBITDA guidance reaffirmed at $160–180 million for Q3 and $670–690 million for full-year 2026.
- Capital expenditures projected at $15–25 million for Q3 and $50–70 million for full-year 2026.
- Company expects $35–55 million in capitalized SaaS implementation costs, excluded from CapEx.
The big picture
Herbalife's reaffirmation of its 2026 guidance underscores its confidence in maintaining steady growth despite macroeconomic challenges. The company's focus on digital transformation and compliance with regulatory frameworks will be critical in navigating the competitive health and wellness sector. With operations spanning over 90 markets, Herbalife's ability to manage foreign exchange risks and capitalize on its direct-selling model will be key to its strategic success.
What we're watching
- Execution Risk
- Whether Herbalife can sustain its projected growth amid global economic uncertainties and foreign exchange fluctuations.
- Regulatory Headwinds
- The impact of ongoing compliance with the FTC Consent Order and potential regulatory actions on the company's operations.
- Technology Integration
- The effectiveness and acceptance of Herbalife's new technology-driven initiatives, particularly SaaS implementation.
Related topics